Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-41.23	44.67	76.02
Graham Fair Price	-12.33	5518.97	6295.00
PEG	17.53	-0.06	0.05
Price/Book	-10.59	1.32	1.48
Price/Cash Flow	9.55	-2.97	-3.28
Prices/Earnings	25.57	10.11	-8.05
Price/Sales	-11.38	2.30	2.60
Price/FCF	9.55	-2.97	-3.28
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	35.25	0.19	0.14
Operating Margin	1528.11	0.04	< 0.005
ROA	-31.39	< 0.005	-0.01
ROE	-0.05	0.03	-28.80
ROIC	< 0.005	< 0.005	978.83
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.03	0.04	-39.51
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.99	16.07	1529.19
EPS QOQ	-1.63	1.74	6.84
FCF QOQ	-1.52	-0.03	98.22
Revenue QOQ	-0.15	0.05	-68.65
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	79.38	243.30	206.51
Days Sales Outstanding (DSO)	107.53	103.33	-3.91
Inventory Turnover	1.13	0.37	-67.37
Debt/Capitalization	0.57	0.55	-2.79
Quick Ratio	0.62	0.44	-28.67
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	6200.23	6442.06	3.90
Cash	6424.12	4152.91	-35.35
Capex	-494.25	-1035.34	-109.48
Free Cash Flow	-2786.96	-2862.38	-2.71
Revenue	3525.81	3695.90	4.82
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.90	0.88	-2.11
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	21.71	17.54	-19.18
Naive Interpretation	Member

06 - Financial Health · Bad

Rating